Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-23-000982
Filing Date
2023-02-03
Accepted
2023-02-03 18:01:08
Documents
1
Period of Report
2023-02-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 6060
  Complete submission text file 0001562180-23-000982.txt   7477
Mailing Address C/O APPLIED THERAPEUTICS, INC. 340 MADISON AVENUE, 19TH FLOOR NEW YORK NY 10173
Business Address
Vignola Mark J. (Reporting) CIK: 0001775429 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39926 | Film No.: 23587711

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Issuer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations